124 related articles for article (PubMed ID: 38244875)
1. Meta-Analysis of STereotactic body radiothERapy in non-spine BONE metastaseS (MASTER-BONES).
Moraes FY; Gouveia AG; Marta GN; da Silva MF; Hamamura AC; Tsakiridis T; Yan M; Viani GA
Int J Radiat Oncol Biol Phys; 2024 Jan; ():. PubMed ID: 38244875
[TBL] [Abstract][Full Text] [Related]
2. Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.
Nguyen EK; Korol R; Ali S; Cumal A; Erler D; Louie AV; Nguyen TK; Poon I; Cheung P; Chu W; Soliman H; Vesprini D; Sahgal A; Chen H
Radiother Oncol; 2023 Sep; 186():109792. PubMed ID: 37414253
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiation Therapy for Metastases in Long Bones.
Madani I; Sahgal A; Erler D; Stish BJ; Olivier KR; Park SS; Eppinga WSC; Seravalli E; Redmond KJ; Cao Y; Siva S; Chang D; Nguyen TK; O'Neil M; Guckenberger M
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):738-746. PubMed ID: 35850362
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
8. Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases.
Burgess L; Nguyen E; Tseng CL; Guckenberger M; Lo SS; Zhang B; Nielsen M; Maralani P; Nguyen QN; Sahgal A
Clin Transl Radiat Oncol; 2024 Mar; 45():100716. PubMed ID: 38226025
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer.
Ito K; Yamaguchi T; Ogawa H; Nakajima Y; Karasawa K
Jpn J Clin Oncol; 2020 Dec; 50(12):1442-1446. PubMed ID: 32719860
[TBL] [Abstract][Full Text] [Related]
10. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
11. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.
Erler D; Brotherston D; Sahgal A; Cheung P; Loblaw A; Chu W; Soliman H; Chung H; Kiss A; Chow E; Poon I
Radiother Oncol; 2018 May; 127(2):304-309. PubMed ID: 29706460
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy to treat breast cancer oligometastases: A systematic review with meta-analysis.
Viani GA; Gouveia AG; Louie AV; Korzeniowski M; Pavoni JF; Hamamura AC; Moraes FY
Radiother Oncol; 2021 Nov; 164():245-250. PubMed ID: 34624408
[TBL] [Abstract][Full Text] [Related]
13. Patient and Treatment Factors Associated With Improved Local Control and Survival in Oligometastatic Bone Disease: Results From a Large Single-Institution Experience Using Stereotactic Body Radiation Therapy.
Thomas MC; Chen YH; Fite E; Pangilinan A; Bubelo K; Spektor A; Balboni TA; Huynh MA
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):747-761. PubMed ID: 35840113
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases.
Owen D; Laack NN; Mayo CS; Garces YI; Park SS; Bauer HJ; Nelson K; Miller RW; Brown PD; Olivier KR
Pract Radiat Oncol; 2014; 4(2):e143-e149. PubMed ID: 24890360
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
[TBL] [Abstract][Full Text] [Related]
16. The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.
Miller JA; Balagamwala EH; Berriochoa CA; Angelov L; Suh JH; Benzel EC; Mohammadi AM; Emch T; Magnelli A; Godley A; Qi P; Chao ST
J Neurosurg Spine; 2017 Oct; 27(4):436-443. PubMed ID: 28731393
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
Moore-Palhares D; Zeng KL; Tseng CL; Chen H; Myrehaug S; Soliman H; Maralani P; Larouche J; Shakil H; Jerzak K; Ruschin M; Zhang B; Atenafu EG; Sahgal A; Detsky J
Int J Radiat Oncol Biol Phys; 2024 Feb; ():. PubMed ID: 38395085
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
[TBL] [Abstract][Full Text] [Related]
19. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes After Stereotactic Body Radiation Therapy for Nonspinal Bone Metastases: A Systematic Review and Meta-analysis.
Singh R; Valluri A; Lehrer EJ; Cao Y; Upadhyay R; Trifiletti DM; Lo SS; Redmond KJ; Sahgal A; Nguyen QN; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Jan; ():. PubMed ID: 38220068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
